¼¼°èÀÇ Ä¡·á ºÐ¾ß °¡»óÇö½Ç ½ÃÀå
Virtual Reality in Therapy
»óǰÄÚµå : 1795208
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 177 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ä¡·á ºÐ¾ß °¡»óÇö½Ç ¼¼°è ½ÃÀåÀº 2030³â±îÁö 64¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 28¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Ä¡·á ºÐ¾ß °¡»óÇö½Ç ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 14.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 64¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿ÏÀü¸ôÀÔÇü VR ±â¼úÀº CAGR 16.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 43¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ý¸ôÀÔÇü VR ±â¼ú ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 11.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 4,210¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 13.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ä¡·á ºÐ¾ß °¡»óÇö½Ç ½ÃÀåÀº 2024³â¿¡ 7¾ï 4,210¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 13.6%·Î 2030³â±îÁö ¿¹Ãø ½ÃÀå ±Ô¸ð 9¾ï 8,390¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 13.6%¿Í 12.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 10.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ä¡·á ºÐ¾ß °¡»óÇö½Ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°¡»óÇö½ÇÀº Ä¡·áÀÇ °üÇà°ú °æÇèÀ» ¾î¶»°Ô À籸¼ºÇϰí Àִ°¡?

°¡»óÇö½Ç(VR)Àº ȯÀÚ°¡ ¿ÏÀüÈ÷ »õ·Î¿î ¹æ½ÄÀ¸·Î Á¤½ÅÀû, À°Ã¼Àû °Ç°­°ú ¼ÒÅëÇÒ ¼ö ÀÖ´Â ¸ôÀÔÇü, ÅëÁ¦µÈ ȯ°æÀ» ¸¸µé¾î³¿À¸·Î½á Ä¡·á ȯ°æÀ» ºü¸£°Ô º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ Ä¡·á´Â ÀÓ»ó ÇöÀå¿¡¼­ÀÇ ¾ð¾îÀû ¼ÒÅë°ú ½ÅüÀû ¿îµ¿¿¡ ÀÇÁ¸ÇØ ¿ÔÁö¸¸, VRÀº ±âÁ¸ÀÇ ¹æ¹ýÀ¸·Î´Â ÀçÇöÇÒ ¼ö ¾ø´Â ¼öÁØÀÇ °¨°¢Àû, »óȲÀû Çö½Ç°¨À» µµÀÔÇϰí ÀÖ½À´Ï´Ù. Çìµå¼Â°ú ¸ð¼Ç ¼¾¼­¸¦ ÅëÇØ ȯÀÚ´Â ºÒ¾È À¯¹ß, °øÆ÷Áõ, Æ®¶ó¿ì¸¶¸¦ À¯¹ßÇÏ´Â »óȲÀ» ÀçÇöÇÑ ½Ã³ª¸®¿À ¾È¿¡¼­ ¿òÁ÷ÀÏ ¼ö ÀÖÀ¸¸ç, Ä¡·á»ç´Â ¾ÈÀüÇÏ°í °¨½ÃµÈ ȯ°æ¿¡¼­ ³ëÃâ ¿ä¹ýÀ» ÁöµµÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ¿Ü»ó ÈÄ ½ºÆ®·¹½º Àå¾Ö, »çȸºÒ¾È, ƯÁ¤ °øÆ÷Áõ µî ´Ü°èÀû Å»°¨ÀÛÀÌ Áß¿äÇÑ Áõ»óÀÇ Ä¡·á¿¡ ƯÈ÷ È¿°úÀûÀÓÀÌ ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. VRÀº Á¤½Å°Ç°­ ºÐ¾ß»Ó¸¸ ¾Æ´Ï¶ó ½Åü ÀçȰ¿¡µµ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¿îµ¿ ½Ã¹Ä·¹À̼Ç, ÀÛ¾÷ °ÔÀÓÈ­, ȯÀÚ ¿òÁ÷ÀÓÀÇ Á¤È®ÇÑ ÃßÀû µîÀ» ÅëÇØ ȯÀÚ¿ÍÀÇ °ü°è ¹× ȸº¹ °á°ú¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. VRÀÌ Á¦°øÇÏ´Â »óÈ£ÀÛ¿ë°ú ¸ôÀÔ°¨Àº ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀ̰í, ÅëÁ¦°¨À» Ű¿ì¸ç, Ä¡·á¹Þ´Â °Í¿¡ ´ëÇÑ ³«ÀÎÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. VR Çϵå¿þ¾î°¡ Àú·ÅÇÏ°í ½±°Ô ±¸ÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó º´¿ø°ú Áø·á¼Ò, ½ÉÁö¾î ÀçÅà °£È£ ÇöÀå±îÁö Ä¡·á ÇàÀ§·ÎÀÇ ÅëÇÕÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü Ä¡·á ÇÁ·Î±×·¥ ¹× ¿ø°Ý Ä¡·á ¼Ö·ç¼ÇÀÇ µîÀåÀº ´Ù¾çÇÑ Áý´Ü°ú Áúȯ¿¡¼­ Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ´Â ¹ü¿ëÀûÀ̰í È®Àå °¡´ÉÇÑ µµ±¸·Î¼­ VRÀÇ ¿ªÇÒÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¾î¶² ±â¼ú Çõ½ÅÀÌ °¡»óÇö½ÇÀÇ Ä¡·á ´É·ÂÀ» È®ÀåÇϰí ÀÖÀ»±î?

Ä¡·á¿¡¼­ °¡»óÇö½ÇÀÇ È¿°ú´Â ¸ôÀÔ°¨, »óÈ£ÀÛ¿ë, ÀÓ»óÀûÀ¸·Î Á¤È®ÇÑ °æÇèÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. °íÇØ»óµµ ±×·¡ÇÈ, °³¼±µÈ ½Ã¾ß, ¹ÝÀÀ¼ºÀÌ ¶Ù¾î³­ ÃßÀû ½Ã½ºÅÛÀ» ÅëÇØ ÀÎÁöÇൿġ·á ¹× ³ëÃâ ±â¹Ý Ä¡·á¿¡ ÇʼöÀûÀÎ ½ÇÁ¦ ½Ã³ª¸®¿À¸¦ Ãæ½ÇÇÏ°Ô ¸ð¹æÇÑ È¯°æÀ» ±¸ÇöÇÕ´Ï´Ù. Ã˰¢ Çǵå¹é ½Ã½ºÅÛÀº ȯÀÚ°¡ °¡»óÀÇ ¹°Ã¼¿Í ¹°¸®ÀûÀ¸·Î »óÈ£ÀÛ¿ëÇÒ ¼ö ÀÖµµ·Ï °³¹ßµÇ¾úÀ¸¸ç, Ä¡·á¿¡ Ã˰¢Àû Â÷¿øÀ» Ãß°¡ÇÏ¿© Ä¡·á¿¡ ´ëÇÑ Âü¿©µµ¿Í Çö½Ç°¨À» ³ô¿©ÁÝ´Ï´Ù. ½Ã¼± ÃßÀû ±â¼úµµ VR Ç÷§Æû¿¡ ÅëÇյǾî ȯÀÚÀÇ ¹ÝÀÀ, ÁÖÀÇ·Â, °¨Á¤ »óŸ¦ ¸ð´ÏÅ͸µÇÔÀ¸·Î½á Ä¡·á»ç´Â ¼¼¼Ç Áß È¯ÀÚÀÇ ÇൿÀ» ´õ ±íÀÌ ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀΰøÁö´ÉÀº ȯÀÚÀÇ ¼º°ú¿Í Çǵå¹é¿¡ µû¶ó Ä¡·á ȯ°æÀ» ¸ÂÃãÈ­Çϰí, ³­À̵µ¸¦ ½Ç½Ã°£À¸·Î Á¶Á¤ÇÏ´Â ¿ªÇÒÀ» ´ã´çÇÕ´Ï´Ù. Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°ú µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ ¿ø°Ý ¸ð´ÏÅ͸µ°ú Àå±âÀûÀÎ °æ°ú ÃßÀûÀÌ °¡´ÉÇØÁ® Ä¡·á °èȹÀ» Àå±âÀûÀ¸·Î Á¶Á¤ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ¸ð¹ÙÀÏ ¹× ¹«¼± VR ½Ã½ºÅÛÀº ¼³Ä¡ÀÇ º¹À⼺À» ÁÙÀÌ°í ±âÁ¸ ÀÓ»ó ȯ°æ ¹Û¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖµµ·ÏÇÔÀ¸·Î½á Ä¡·á¸¦ ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Á¤½Å°Ç°­ Àü¹®°¡¿Í Çù·ÂÇÏ¿© °³¹ßµÇ¾úÀ¸¸ç, Ä¡·á ³»¿ëÀÌ Áõ°Å¿¡ ±â¹ÝÇϰí ÀÓ»ó ±âÁØ¿¡ ºÎÇÕÇϵµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀÌ °è¼Ó ¼º¼÷ÇØÁü¿¡ µû¶ó ¸¸¼º ÅëÁõ°ú ³úÁ¹Áß È¸º¹ºÎÅÍ ¼·½Ä Àå¾Ö¿Í ÀÚÆóÁõ°ú °°Àº ¹ß´Þ Àå¾Ö¿¡ À̸£±â±îÁö VR·Î Ä¡·áÇÒ ¼ö ÀÖ´Â Áõ»óÀÇ ¹üÀ§°¡ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû ÁøÈ­´Â °¡»óÇö½Ç Ä¡·áÀÇ È¿°ú¸¦ ³ôÀÏ »Ó¸¸ ¾Æ´Ï¶ó È®À强À» ³ô¿© ´õ ±¤¹üÀ§ÇÑ ÀÇ·á ½Ã½ºÅÛ¿¡ ÅëÇÕÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

ȯÀÚ¿Í ÀÇ·áÁøÀÌ °¡»óÇö½ÇÀ» Ä¡·á µµ±¸·Î äÅÃÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Ä¡·á¿¡¼­ °¡»óÇö½ÇÀÇ µµÀÔÀÌ È®´ëµÇ°í ÀÖ´Â ÀÌÀ¯´Â ȯÀÚ¿Í Ä¡·áÀÚ ¸ðµÎ¿¡°Ô Ä¡·á °æÇèÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ȯÀڵ鿡°Ô VRÀº ±âÁ¸ Ä¡·á¹ýÀ¸·Î´Â ´Þ¼ºÇϱ⠾î·Á¿î ¸ôÀÔ°¨°ú Âü¿©µµ¸¦ Á¦°øÇÕ´Ï´Ù. °¡»ó ȯ°æÀÇ ½Ã°¢Àû, °¨°¢Àû dz¿ä·Î¿òÀº ȯÀÚÀÇ ¸ôÀÔ°¨°ú ÁýÁß·ÂÀ» ³ô¿© Ä¡·á °á°úÀÇ Çâ»óÀ¸·Î À̾îÁý´Ï´Ù. VRÀº ºñÇà±â °øÆ÷ÁõÀÌ ÀÖ´Â »ç¶÷ÀÌ ºñÇà±â¸¦ Ÿ°Å³ª PTSD¸¦ ¾Î°í ÀÖ´Â Å𿪠±ºÀÎÀÌ ÀüÅõ »óȲ¿¡ Á÷¸éÇÏ´Â µî ½Ç»ýȰ¿¡¼­ ÀçÇöÇÏ±â ¾î·Æ°í À§ÇèÇÏ¸ç ºñÇö½ÇÀûÀÎ ½Ã³ª¸®¿À¸¦ ½Ã¹Ä·¹À̼ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ Ä¡·á»ç´Â ¾ÈÀü¼ºÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í Á¡ÁøÀûÀ¸·Î Á¦¾îµÈ ³ëÃâÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ ÀÔÀå¿¡¼­´Â VR Ä¡·áÀÇ °ÔÀÓÈ­ Ãø¸éÀÌ ¿îµ¿ÀÇ Àç¹Ì¸¦ ´õÇϰí, Âü¿©¿¡ ´ëÇÑ ÀúÇ×À» ÁÙ¿© µ¿±âºÎ¿©¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. Ä¡·áÀÚ ÀÔÀå¿¡¼­´Â VR µµ±¸°¡ ±¸Á¶È­µÇ°í ¹Ýº¹ °¡´ÉÇÑ °³ÀÔÀ» Á¦°øÇϱ⠶§¹®¿¡ ÁøÇà »óȲÀ» ÃßÀûÇϰí, ¹ÝÀÀÀ» ÃøÁ¤Çϰí, ±×¿¡ µû¶ó Ä¡·á¸¦ Á¶Á¤ÇÏ´Â °ÍÀÌ ¿ëÀÌÇØÁý´Ï´Ù. ¶ÇÇÑ, Ä¡·á»ç´Â ¼Óµµ ºÐ¹è¿Í »óÈ£ÀÛ¿ëÀÇ À¯¿¬¼ºÀ» À¯ÁöÇϸ鼭 Ç¥ÁØÈ­µÈ °æÇèÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, VR ¼¼¼Ç Áß¿¡ ¼öÁýµÈ µ¥ÀÌÅÍ´Â Ä¡·á Á¢±Ù¹ýÀ» °³¼±Çϰí Ä¡·á °á°ú¸¦ °ËÁõÇÏ´Â µ¥ Ȱ¿ëµÉ ¼ö ÀÖ½À´Ï´Ù. ¿ø°ÝÄ¡·á°¡ º¸ÆíÈ­µÊ¿¡ µû¶ó VRÀº ¿ø°ÝÀ̸鼭µµ ±íÀÌ ÀÖ´Â »óÈ£ÀÛ¿ëÀÌ °¡´ÉÇÑ Ä¡·áÀÇ »õ·Î¿î °¡´É¼ºÀ» ¿­¾îÁÝ´Ï´Ù. ÀÌ´Â Àü¹®ÀûÀÎ Ä¡·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑµÉ ¼ö ÀÖ´Â ÀÇ·á¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀ̳ª Áö¹æ¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. »ç¿ëÀÚµéÀÇ ±àÁ¤ÀûÀÎ Çǵå¹é°ú ±× È¿°ú¿¡ ´ëÇÑ ÀÓ»óÀû ±Ù°Å°¡ Áõ°¡ÇÔ¿¡ µû¶ó, VRÀº ´õ ÀÌ»ó »õ·Î¿î °ÍÀÌ ¾Æ´Ï¶ó Ä¡·á Ä¡·áÀÇ Á¤´çÇÏ°í °¡Ä¡ ÀÖ´Â ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Ä¡·á ºÐ¾ß¿¡¼­ °¡»óÇö½ÇÀÇ È®ÀåÀ» ÁÖµµÇÏ´Â ½ÃÀå µ¿·Â°ú ÇコÄÉ¾î µ¿ÇâÀº ¹«¾ùÀΰ¡?

Ä¡·á ºÐ¾ß °¡»óÇö½Ç ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú µµÀÔ, ÀÇ·á ½Ã½ºÅÛ º¯È­, Á¤½Å°Ç°­ ÀνÄÀÇ Áõ°¡¿Í °°Àº ¸î °¡Áö °­·ÂÇÑ Èû¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Å« ¿øµ¿·Â Áß Çϳª´Â ºÒ¾È, ¿ì¿ïÁõ, PTSD ¹× ±âŸ ½É¸® »óÅÂÀÇ ºñÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º¸´Ù È¿°úÀûÀÌ°í ¸Å·ÂÀûÀÎ Ä¡·á ¹æ¹ýÀ» ã°Ô µÈ ¼¼°è Á¤½Å°Ç°­ À§±âÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº ƯÈ÷ ¼÷·ÃµÈ Á¤½Å°Ç°­ Àü¹®°¡°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­´Â VRÀ» ÅëÇØ ´ë±Ô¸ð·Î ¿µÇâ·Â ÀÖ´Â Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ¸·Î ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, °³ÀÎÈ­µÈ ȯÀÚ Áß½É Ä¡·á·ÎÀÇ ±¤¹üÀ§ÇÑ ÀüȯÀº VR Ä¡·áÀÇ ¸ÂÃãÇü Ư¼º°ú ¿Ïº®ÇÏ°Ô ÀÏÄ¡ÇÕ´Ï´Ù. º¸Çè»ç ¹× Á¤Ã¥ ÀÔ¾ÈÀÚµéÀº ÀÌ·¯ÇÑ °³ÀÔÀÇ °¡Ä¡¸¦ ÀνÄÇϱ⠽ÃÀÛÇßÀ¸¸ç, ÀÌ´Â VR ±â¹Ý Ä¡·á¸¦ µµÀÔÇÑ ½Ã¹ü ÇÁ·Î±×·¥ ¹× »óȯ ¸ðµ¨·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº ±âÁ¸ ´ë¸é Ä¡·áÀÇ ÇѰ踦 µå·¯³½ COVID-19 »çÅ·ΠÀÎÇØ °¡¼ÓÈ­µÈ ¿ø°Ý Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. VR Ç÷§ÆûÀº Áý¿¡¼­ Á¢±ÙÇÒ ¼ö ÀÖ´Â ¸ôÀÔÇü °¡À̵å Å×¶óÇÇ °æÇèÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ °£±ØÀ» ¸Þ¿ì°íÀÚ ÇÕ´Ï´Ù. º¥Ã³ ijÇÇÅÐÀÇ ÅõÀÚ, ÇÏÀÌÅ×Å© ±â¾÷°ú ÇコÄɾî Á¦°ø¾÷ü¿ÍÀÇ Á¦ÈÞµµ ±â¼ú Çõ½Å¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ¸ç ½ÃÀåÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±³À°±â°ü°ú ¿¬±¸¼¾ÅÍ´Â ´ëÁ¶±º ½ÃÇè°ú °á°ú ¿¬±¸¸¦ ÅëÇØ VR Ä¡·áÀÇ ÀÓ»óÀû À¯È¿¼ºÀ» °ËÁõÇÏ´Â ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀ» ¼±È£ÇÏ´Â Á¡Á¡ ´õ ±â¼ú¿¡ Á¤ÅëÇÑ »ç¶÷µé¿¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå µ¿Çâ¿¡ µû¶ó °¡»óÇö½ÇÀº Ä¡·á »ýŰèÀÇ ÇʼöÀûÀÎ ºÎºÐÀ¸·Î ÀÚ¸® Àâ°í ÀÖÀ¸¸ç, Á¤½Å ¹× ½Åü °Ç°­ Ä¡·á¿¡ ´ëÇÑ È®À强, µ¥ÀÌÅÍ ±â¹Ý, ȯÀÚ Ä£È­ÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

±â¼ú(¿ÏÀü¸ôÀÔÇü VR ±â¼ú, ¹Ý¸ôÀÔÇü VR ±â¼ú, ºñ¸ôÀÔÇü VR ±â¼ú), µð¹ÙÀ̽º(Çìµå ¸¶¿îÆ® µð¹ÙÀ̽º, Á¦½ºÃ³ ÄÁÆ®·Ñ µð¹ÙÀ̽º, ÇÁ·ÎÁ§ÅÍ µð¹ÙÀ̽º), ¿ëµµ(°øÆ÷Áõ Ä¡·á ¿ëµµ, ·Îº¿ ¼ö¼ú ¿ëµµ, ½Ã°¢È­ ¿ëµµ, ÀçȰ ¿ëµµ, ¿Ü»ó ÈÄ ½ºÆ®·¹½º Àå¾Ö Ä¡·á ¿ëµµ, ÀÚÆóÁõ Ä¡·á ¿ëµµ, ¼ö¼ú ½Ã¹Ä·¹ÀÌ¼Ç ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Virtual Reality in Therapy Market to Reach US$6.4 Billion by 2030

The global market for Virtual Reality in Therapy estimated at US$2.8 Billion in the year 2024, is expected to reach US$6.4 Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2024-2030. Full Immersive VR Technology, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Semi-Immersive VR Technology segment is estimated at 11.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$742.1 Million While China is Forecast to Grow at 13.6% CAGR

The Virtual Reality in Therapy market in the U.S. is estimated at US$742.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$983.9 Million by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.6% and 12.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.

Global Virtual Reality in Therapy Market - Key Trends & Drivers Summarized

How Is Virtual Reality Reshaping the Practice and Experience of Therapeutic Treatment?

Virtual reality (VR) is rapidly transforming the landscape of therapeutic treatment by creating immersive, controlled environments that enable patients to engage with their mental and physical health in entirely new ways. Traditionally, therapy has relied on verbal communication and physical exercises within clinical settings, but VR introduces a level of sensory and situational realism that cannot be replicated through conventional methods. Through headsets and motion sensors, patients can now be transported into scenarios that replicate anxiety triggers, phobias, or trauma-inducing situations, allowing therapists to guide exposure therapy in a safe and monitored environment. This technology is proving especially effective in treating conditions such as post-traumatic stress disorder, social anxiety, and specific phobias, where gradual desensitization is critical to progress. Beyond mental health, VR is also being utilized in physical rehabilitation by simulating exercises, gamifying tasks, and tracking patient movements with precision, thereby improving engagement and recovery outcomes. The level of interactivity and immersion provided by VR encourages greater patient compliance, fosters a sense of control, and reduces the stigma sometimes associated with seeking therapy. As VR hardware becomes more affordable and accessible, its integration into therapeutic practices is expanding across hospitals, clinics, and even home-care settings. The rise of personalized therapy programs and remote care solutions further supports VR’s role as a versatile and scalable tool that enhances therapeutic efficacy across diverse populations and conditions.

What Technological Innovations Are Expanding the Capabilities of Virtual Reality in Therapy?

The effectiveness of virtual reality in therapy is being significantly enhanced by ongoing technological advancements that are making the experiences more immersive, interactive, and clinically precise. High-resolution graphics, improved field of view, and more responsive tracking systems are creating environments that closely mimic real-world scenarios, which is essential for cognitive behavioral therapies and exposure-based treatments. Haptic feedback systems are being developed to allow patients to physically interact with virtual objects, adding a tactile dimension to therapy that increases engagement and realism. Eye-tracking technology is also being integrated into VR platforms to monitor patient responses, attention, and emotional states, giving therapists deeper insights into patient behavior during sessions. Artificial intelligence is playing a role in customizing therapeutic environments and adjusting difficulty levels in real time based on patient performance and feedback. Cloud computing and data analytics are enabling remote monitoring and long-term progress tracking, which supports therapists in tailoring treatment plans over time. Additionally, mobile and wireless VR systems are making therapy more accessible by reducing setup complexity and allowing use outside traditional clinical settings. These innovations are being developed in collaboration with mental health professionals, ensuring that therapeutic content is evidence-based and aligned with clinical standards. As these technologies continue to mature, they are broadening the scope of conditions that can be treated with VR, from chronic pain and stroke recovery to eating disorders and developmental conditions like autism. This technological evolution is not only increasing the effectiveness of virtual reality therapy but also improving its scalability and integration into broader healthcare systems.

Why Are Patients and Practitioners Increasingly Embracing Virtual Reality as a Therapeutic Tool?

The growing adoption of virtual reality in therapy is largely fueled by its ability to enhance the treatment experience for both patients and practitioners. For patients, VR provides a level of immersion and engagement that traditional therapy often struggles to achieve. The visual and sensory richness of virtual environments helps patients feel more present and focused, which can lead to better therapeutic outcomes. VR can simulate scenarios that are otherwise difficult, dangerous, or impractical to recreate in real life, such as flying in an airplane for someone with aviophobia or confronting combat situations for veterans with PTSD. This enables therapists to provide gradual and controlled exposure without compromising safety. From a patient’s perspective, the gamification aspects of VR therapy can make exercises more enjoyable, reducing resistance to participation and increasing motivation. On the practitioner side, VR tools offer structured and repeatable interventions, making it easier to track progress, measure responses, and adjust treatments accordingly. They also allow therapists to deliver standardized experiences while maintaining flexibility in pacing and interaction. Furthermore, the data collected during VR sessions can be used to refine therapeutic approaches and validate treatment outcomes. As teletherapy becomes more common, VR also opens up new possibilities for remote yet deeply interactive care. This is particularly important in underserved or rural areas where access to specialized therapy services may be limited. The positive feedback from users, combined with growing clinical evidence of its efficacy, is establishing VR not as a novelty but as a legitimate and valuable component of therapeutic care.

What Market Forces and Healthcare Trends Are Driving the Expansion of Virtual Reality in Therapy?

The growth in the virtual reality in therapy market is driven by several powerful forces tied to technological adoption, healthcare system transformation, and rising mental health awareness. One major driver is the global mental health crisis, with increasing rates of anxiety, depression, PTSD, and other psychological conditions prompting the search for more effective and engaging treatment modalities. Healthcare providers are turning to VR as a solution that can deliver impactful therapy at scale, especially in regions where there is a shortage of trained mental health professionals. At the same time, the broader shift toward personalized and patient-centered care aligns perfectly with the customizable nature of VR therapy. Insurance providers and policymakers are beginning to recognize the value of these interventions, leading to pilot programs and reimbursement models that incorporate VR-based treatments. Another important factor is the rise in demand for remote care solutions, accelerated by the COVID-19 pandemic, which exposed the limitations of traditional in-person therapy. VR platforms are filling this gap by offering immersive, guided therapy experiences that can be accessed from home. Investments from venture capital and partnerships between tech companies and healthcare providers are also fueling innovation and expanding market reach. Additionally, educational institutions and research centers are playing a role by validating the clinical efficacy of VR therapy through controlled trials and outcome studies. These developments are supported by an increasingly tech-savvy population that is open to digital health solutions. As these market trends converge, virtual reality is becoming an integral part of the therapeutic ecosystem, offering scalable, data-driven, and patient-friendly approaches to mental and physical health treatment.

SCOPE OF STUDY:

The report analyzes the Virtual Reality in Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Full Immersive VR Technology, Semi-Immersive VR Technology, Non- Immersive VR Technology); Device (Head Mount Device, Gesture Control Device, Projectors Device); Application (Phobia Treatment Application, Robotic Surgery Application, Visualization Application, Rehabilitation Application, Treatment of Post-Traumatic Stress Disorder Application, Treatment of Autism Application, Surgery Simulation Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 37 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â